Towards governance of human tissue engineered technologies in Europe: Framing the case for a new regulatory regime

Technological Forecasting and Social Change

Volumn 73, Issue 1, 2006, Pages 41-60

  Kent, Julie ^a   Faulkner, A ^b   Geesink, I ^b   FitzPatrick, D ^c  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

European Commission; Human tissue engineered technologies; Regulation and governance; Risk regulation

Indexed keywords

BIOTECHNOLOGY; ECONOMIC AND SOCIAL EFFECTS; LAWS AND LEGISLATION; PRODUCT DEVELOPMENT; PUBLIC POLICY; RISK ASSESSMENT; SOCIETIES AND INSTITUTIONS; TISSUE CULTURE;

EUROPEAN COMMISSION (CO); HUMAN TISSUE ENGINEERED TECHNOLOGIES; RISK REGULATION; SOCIAL SHAPING; TECHNICAL RISK ASSESSMENT;

TECHNOLOGICAL FORECASTING;

BIOTECHNOLOGY; ENGINEERING; GOVERNANCE APPROACH; REGULATORY APPROACH; RISK ASSESSMENT;

EID: 30944446375     PISSN: 00401625     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.techfore.2005.06.006     Document Type: Article

References (74)

1. U. Beck Risk Society Towards a New Modernity 1992 Sage London
2. S. Krimsky Risk assessment and regulation of bioengineered food products Int. J. Biotechnol. 2 1/2/3 2000 231-238
3. Scoones, I. (2002) Science, policy and regulation: Challenges for agricultural biotechnology in developing countries. Working Paper 147 Institute of Development Studies, Brighton, July 2001 ISBN 1 85864 403 8.
4. Newell, P. (2002) Biotechnology and the politics of regulation, Working Paper 146. Institute of Development Studies, Brighton. ISBN 1 85864 399 6.
5. D. Vogel The new politics of risk regulation in Europe CARR Discussion paper, LSE London http://www.lse.ac.uk/Depts/carr/ Publications_folder_web_filesDisspaper3.pdf. 2001 (Accessed 01/04/03)
6. J. Kent A. Faulkner Regulating human implant technologies in Europe - understanding the new regulatory era in medical device regulation Health, Risk Soc. 4 2 2002 189-209
7. M. Jones B. Salter The governance of human genetics: Policy discourse and constructions of public trust New Genet. Soc. 22 1 2003 21-41
8. J. Abraham T. Reed Progress, innovation and regulatory science in drug development: The politics of international standard-setting Soc. Stud. Sci. 32 3 2002 337-369
9. M. Moran The rise of the regulatory state in Britain Parliam. Aff. 54 1 2001 15-31
10. B. Salter M. Jones Regulating human genetics: The changing politics of biotechnology governance in the European Union Health, Risk Soc. 4 3 2002 325-340
11. J. Abraham G. Lewis Citizenship, medical expertise and the capitalist regulatory state in Europe Sociology 36 1 2002 67-88
12. J. Law W. Bijker Postcript: Technology, stability and social theory W. Bijker J. Law Shaping Technology/Building Society: Studies in Sociotechnical Change 1992 MIT Press
13. J. Lang European parliament hearing on DG Sanco proposal COM (2002) 319 Final, Smith and Nephew Wound Management, UK at http://www.eutop.de/ct 2003 (Accessed 3/2/03)
14. Pickup, S. (2002) Personal communication, (23 December).
15. E. Schutte Industry position on proposed directive (representing Eucomed) Presentation at Public Hearing Quality and Safety of Human Tissue and Cells 2003 (29 Jan) European Parliament Brussels http://www.eutop.de/ct/
16. World Technology Evaluation Centre (WTEC) (2002) Panel report on "Tissue Engineering Research" At: http://wtec.org/loyola/te/final/
17. M. Lysaght J. Reyes The growth of tissue engineering Tissue Eng. 7 5 2001 485:93
18. IsoTis (2002) Swiss authorities refuse reimbursement for range of innovative therapies, Including EpiDex T. Press Release December 18th 2002 http://www.isotis.com
19. A. Bouchie Tissue Engineering firms go under Nat. Biotechnol. 20 2002 1178-1179 http://www.nature.com/cgi-taf/DynaPage.taf?file=/nbt/journal/v20/n12/ full/nbt1202-1178.html
20. Pittsburgh Tissue Engineeringing Initiative 2003, at: http://www.pittsburgh-tissue.net/
21. Smith, D. (2002) Legal and Regulatory Issues in World Technology Evaluation Centre panel report, on Tissue Engineering Research, http://www.wtec.org. Accessed July 2002.
22. S. Bartlett Foote Medical Technology Leadership Forum Summit, Defining a Regulatory Process for Combination Products: The Emergence of Tissue Engineering 2002 http://www.mtlf.org. Accessed July 2002
23. EUCOMED Eucomed response to European Commission DG Enterprise Consultation Document'Need for a Legislative Framework for Human Tissue Engineering and Tissue-Engineered Products' 2003 http://www.eucomed.be.org/?x+4&y=11&z=218 Accessed January 2003
24. EUCOMED (2001b) Eucomed calls for clear and appropriate EU regulatory framework for human tissue engineered medical technologies, Press release, issue 25/01, Brussels, November 9.
25. EUCOMED Industry Position on Human Tissue Product Regulation 2001 at: http://www.eucomed.be/?x+2+y+29&z=58&id=97
26. P. Brown G. Dombal D. Dornbusch B. Elsami et al. Human cell- and tissue-based products: Progress, promise and regulatory issues J. Commer. Biotechnol. 7 4 2001 287-298
27. B. Indech The international harmonization of human tissue regulation: regulatory control over human tissue use and tissue banking in select countries and the current state of international harmonization efforts Food Drug Law J. 55 2000 342-372
28. K. Hellman Bioartificial organs as outcomes of Tissue Engineering. Scientific and regulatory issues Ann. N.Y. Acad. Sci. 831 1997 1-9
29. M. Cox, J. Tinkler, Biomaterials regulation: Innovative products - outgrowing the European framework? Action for Biomaterials, Issue 4, May, (2000).
30. A. Faulkner J. Kent Innovation and regulation in human implant technologies: Developing comparative approaches Soc. Sci. Med. 53 2001 895-913
31. J. Abraham G. Lewis Regulating Medicines in Europe: Competition, Expertise and Public Health 2002 Routledge London
32. D. Williams Clarity and Risk: The Challenges of the New Technologies. Medical Device Technology, Features: Materials 2001 http://www.medicaldevicesonline.com/features/story.epml?features.REF=43
33. P. Pascal O. Damour J. Colpart F. Braye French legal framework relating to human tissues and cells Med. Biol. Eng. Comput. 38 2000 241-247
34. Elmalem, S. (2002) In search of a regulatory framework for human tissue and cell-based products in Europe. Thesis for the post-graduate diploma (DESS) of International Drug Development and Registration, France.
35. Department of Health Guidance Notes on the Processing, Storage and Issue of Bone Marrow and Blood Stem Cells 1997 Department of Health
36. Department of Health Review of Guidance on the Research Use of Foetuses and Fetal Material 1989 Department of Health
37. Department of Health Guidance on the Microbiological Safety of Human Organs, Tissues and Cells Used in Transplantation, Advisory Committee on the Microbiological of Safety Blood and Tissues for Transplantation 2000 Department of Health
38. M. Cox J. Tinkler Biomaterials regulation: Innovative products - outgrowing the European Framework? Action Biomater. 2000 (May issue, The Biomaterials Partnership)
39. Medical Research Council MRC Human tissue and biological samples for use in research Interim Operational and Ethical Guidelines Issued by the Medical Research Council 1999 Medical Research Council London
40. Department of Health Draft Code of Practice on the Import and Export of Human Body Parts 2002 Department of Health
41. Department of Health A Code of Practice for Tissue Banks Providing Tissues of Human Origin for Therapeutic Purposes 2001 Department of Health
42. Department of Health (2002b) Human Bodies, Human Choices, The Law on Human Organs and Tissue in England and Wales. A Consultation Report, Department of Health.
43. C. Womack N. Gray Human research tissue banks in the UK National Health Service: Laws, ethics, controls and constraints Br. J. Biomed. Sci. 57 2000 250-253
44. Scheper-Hughes, N. (2001) Bodies for sale - whole or in parts in special issue of Body and Society, 7, 2-3, 1-8.
45. Department of Health (2002c) Human Bodies, Human Choices, The Law on Human Organs and Tissue in England and Wales. Report on Responses to Consultation, Department of Health.
46. Department of Health Proposals for New Legislation on Human Organs and Tissue 2003 Department of Health
47. EU Commission/DG Sanco Proposal for a European and Council Directive on Setting Standards of Quality and Safety for the Donation, Procurement, Testing, Processing, Storage, and Distribution of Human Tissues and Cells. COM (2002) 319 final June 2002) 2002 at: http://www.eutop.de/ct/com2002-319en.pdf.
48. EU Commission/DG Sanco Amended Proposal for a European and Council Directive on Setting Standards of Quality and Safety for the Donation, Procurement, Testing, Processing, Storage, and Distribution of Human Tissues and Cells. COM (2003) 340 final May 2003 2003 http://europa.eu.int/eur-lex/en/com/pdf/2003/com2003_0340en01.pdf
49. Altenstetter, C. (2001) EU policies on the regulation of medical goods and equipment, paper prepared for 29th ECPR Joint Workshops, Grenoble, France, April 6-11th. (unpublished).
50. C. Hood H. Rothstein R. Baldwin The Government of Risk: Understanding Risk Regulation Regimes 2001 Oxford University Press
51. Anonymous Human tissues and cells: EU-wide legislation welcome, details to be clarified at http://www.euractiv.com/cgi-bin/cgint.exe/3722566-90?targ= 1&204&OIDN=1504578&-home=search 2003 Accessed 21/03/2003
52. EUCOMED (2003) Quality and Safety of Human Tissues and Cells: Eucomed Position on Commission Proposal for a Directive, The European Medical Technology Industry Association, Press Release Issue 05/03, http://www.eucomed.org. Accessed January 2003.
53. EUCOMED (2003) Press Release February 5th: Quality and safety of human tissues and cells: Eucomed position on Commission Proposal for a Directive at: Http://www.eucomed.org
54. EuropaBio (2003) Presentations by Luyten, F and Fuerst-Ladani, S. on Behalf of EuropaBio at Public Hearing Quality and Safety of Human Tissue and Cells, European Parliament Brussels, 29th Jan. 2003. http://www.eutop.de/ct//
55. Fieldsend, D. Presentation at public hearing quality and safety of human tissue and cells, European Parliament Brussels, 29 Jan 2003 http://www.eutop.de/ct/Download/Fieldsend-Declaration-EN.pdf
56. O'Floinn, A. (2003) Presentation at public hearing quality and safety of human tissue and cells, European Parliament Brussels, 29 Jan 2003 http://www.eutop.de/ct/Download/OFloinn.pdf
57. Mieth, D. (2003) Presentation at public hearing quality and safety of human tissue and cells, European Parliament Brussels, 29 Jan 2003 http://www.eutop.de/ct/Download/Mieth2.pdf
58. Tambuyzer, E. (2003) Presentation at public hearing quality and safety of human tissue and cells, European Parliament Brussels, 29 Jan 2003 http://www.eutop.de/ct/
59. EU Commission/DG Enterprise Need for a Legislative Framework for Human Tissue Engineered Products 2002 http://europa.eu.int/comm/enterprise/medical_devices/ consult_tissue_engineer.htm
60. T. Chignon Initiatives to Harmonize Regulations of Human Tissue/Cell Products in the European Union 2003 at: http://www.raps.org.rainterative/articlewinter2003.cfm?article_ID=97 Accessed January 2003
61. EU Commission/DG Enterprise Results of the Consultation on the Need for a Community Legal Framework on 'Human Tissue Engineered Products' 2003 http://europa.eu.int/comm/enterprise/medical_devices/ consultation_results.pdf
62. Scientific Committee on Medicinal Products and Medical Devices SCMPMD Opinion on the State of the Art Concerning Tissue Engineering 2001 at http://europa.eu.int/comm/food/fs/sc/scmp/out37_en.pdf Accessed 18/03/03
63. G. Naughton An industry imperiled by regulatory bottlenecks Nat. Biotechnol. 19 2001 709-710
64. Anonymous Tissue Engineering Nat. Biotechnol. 18 supplement IT56-58 2000
65. P. Whiteside Regulation of Cell-Based Therapies in the EU, Regulatory Affairs Professionals Society RA Interactive 2003 at: http://www.raps.org/rainteractive/articlewinter2003.cfm?article_ID=91 Accessed 17/1/03
66. Schutte, E. (2002) European regulatory barriers to Tissue Engineering products. Unpublished.
67. Medical Device Agency MDA A Code of Practice for the Production of Human-Derived Therapeutic Products 2002 Department of Health London
68. J. Kent Lay experts and the politics of breast implants Public Underst. Sci. 12 4 2003 403-422
69. Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on Setting Standards of Quality and Safety for the Donation, Procurement, testing, processing, preservation, storage and distribution of human tissues and cells Official Journal L102 2004 48-58
70. Council of Europe Guide to Safety and Quality Assurance for Organs, Tissues and Cells 2002 Council of Europe Publishing
71. DG Enterprise Proposal for a Harmonised Regulatory Framework on Human Tissue Engineered Products: DG Enterprise Consultation paper 6th April 2004 http://pharmacos.eudra.org/F3/human-tissue/Doc1.htm.
72. J. Abraham T. Reed Trading risks for markets: The international harmonisation of pharmaceuticals regulation Health, Risk Soc. 3 2001 113-128
73. J. Abraham T. Reed Reshaping the carcinogenic risk assessment of medicines Soc. Sci. Med. 57 2003 195-204
74. Institute of Prospective Technological Studies (2004) Human tissue-engineered Products. Today's markets and future prospects. European Joint Research Centre Report EUR 21000 EN.